CompletedNCT02046200
Ivermectin Safety and Early Effects for Alcohol Use
About this title
Read the official source — NCT02046200Medication studyAges 21–65United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 21 years to 65 years.
- Listed locations
- Los AngelesSee all locations and recruitment
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
Study start dateFebruary 2014
- Recruitment status
- Completed
- Enrollment listed in the registry
- 11
- Sponsor
- University of California, Los Angeles
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 21 Years to 65 Years
- Official registry ID
- NCT02046200
- Official title
Show the full official title
Repositioning Ivermectin for the Treatment of Alcohol Use Disorders
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Los Angeles
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of California, Los Angeles, a university.
Did this study involve medication?
Yes. The study involved medication, including Ivermectin, Placebo and Alcohol.
Who was this study for?
Listed age limits: 21 years to 65 years.
